ÁñÁ«ÊÓƵ

This nonrandomized controlled trial assesses the safety and clinical activity of anti–PD-1 therapy to treat high-risk proliferative verrucous leukoplakia.

This nonrandomized phase 2 clinical trial assesses the usefulness of osimertinib in previously untreated patients with metastatic non–small cell lung cancer (NSCLC) harboring uncommon EGFR mutations, excluding exon 20 insertion mutations.

This cohort study investigates stage-specific rates and timing of colorectal cancer recurrence using data from Danish national health registries from 2004 to 2019.

This Swedish cohort study examines long-term outcomes after a false-positive mammography result and investigates whether the association of a false-positive mammography result with cancer differs by baseline characteristics, tumor characteristics, and time since the false-positive result.

This systematic review with meta-analysis examines the global distribution of breast cancer stage by country, age group, calendar period, and socioeconomic status using population-based data.

This case series describes organ preservation trends among patients with rectal cancer in the US from 2006 to 2020.

This multicenter intervention study conducted at 4 hospital pharmacies in the Netherlands assessed waste reduction and net cost savings attained by redispensing leftover oral anticancer drugs compared with the standard practice of disposal.

This quality improvement study examines the effectiveness of a learning program for molecular tumor boards to share best practices for providing optimal treatment recommendations in 50 identical simulated cases of advanced cancer.